Skip to content

Clinical trials

Phase 2 Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2 Country / region: Singapore Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20141
20154
20161
20172
20181
20191
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Completed5
Unknown status4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University Hospital, Singapore4
National University of Singapore2
Amgen1
Bayer1
Celgene1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1
National Cancer Institute (NCI)1
National Hospital Organization Nagoya Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms15
Breast Neoplasms2
Cognitive Dysfunction2
Anxiety Disorders1
Biliary Tract Neoplasms1
Bone Marrow Diseases1
Brenner Tumor1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Down Syndrome1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.